This includes optimizing metabolic health, reducing chronic inflammation, supporting hormone balance, and protecting cognitive and physical function over time
Notably, this pro-tumorigenic effect was absent at a concentration of 50 nM, suggesting that the carcinogenic potential of liraglutide is concentration-dependent [18]
However, compounded drugs are not FDA-approved and may be associated with higher safety concerns and product quality issues
[15] [16] In the brain, GLP-1 receptor activation has been linked with neurotrophic effects including neurogenesis [17] [18] and neuroprotective effects including reduced necrotic [19] and apoptotic [20] [19] signaling, cell death, [21] [22] and dysfunctions
For juvenile arthritis and ankylosing spondylitis, we don't really have robust clinical data evaluating these therapies